Mitolyn Fake Reviews Exposed : What You Need to Know Before You Purchasing Mitolyn(Real User Report)
[Mitolyn Fake Reviews: Know This Before Making A Purchase]
PORTLAND, Ore., May 14, 2025 (GLOBE NEWSWIRE) -- Are you someone who has faced bullying and teasing for your weight? If you are like anything that I was: obese, low on energy, exhausted with strict diets, unable to follow heavy workouts, and tired of trying numerous dietary supplements, then Mitolyn is for you. Mitolyn is a dietary formula that claims to help users shed weight and stubborn fat in a matter of a few months.
Having said to have been formulated with scientifically proven ingredients and manufactured under strict, sterile, and certified lab facilities, Mitolyn claims to offer a side-effect-free experience, which will be cross-examined in this Mitolyn review.
[READ BEFORE YOU BUY: What Doctors Are Saying About Mitolyn Might Shock You]
Under today's lifestyle and living conditions, obesity is a very common problem. So many of you are going through situations similar to the ones I have been in. As a person who has overcome this, I am very well aware of that pathetic and frustrating situation. However, our frustration should not lead us to unworthy decisions. So, this review will analyze different aspects of Mitolyn, including its working, ingredients, side effects, benefits, drawbacks, pricing, availability, return policy, and more. So, let's begin.
New to Mitolyn? Here's Everything You Should Know
Mitolyn is a natural, plant-based formula that helps users get rid of their stubborn fat and gain a dream body. According to my experience, this supplement is a good initiative for mitochondrial health and weight loss. As mentioned on the official website, Mitolyn is formulated with a blend of six scientifically proven ingredients that promote calorie burning and faster weight loss. As these ingredients are proven to be safe and effective, Mitolyn has no traces of GMOs, BPO, or other toxins, leaving no room for side effects or allergies. Moreover, the manufacturers have ensured that the supplement is developed under strict and sterile conditions that are approved and certified by the FDA and GMP.
[Thinking About Trying Mitolyn? Here's What Doctors Want You to Know ]
The capsule design and usage instructions also make Mitolyn ideal for all adults, regardless of their age, gender, or lifestyle. The customer-friendly policies and offers have also proved Miytolyn to be a reliable formula. With multiple packages, significant discounts, free bonuses, and a 90-day money-back guarantee, Mitolyn proves to be worthy of trying. So, as the first glance is completed, I will be detailing the work and other details in the coming sections.
What Happens in Your Body When You Take Mitolyn
I have already mentioned that Mitolyn is a supplement for mitochondrial health and weight loss. But how is mitochondrial health related to weight loss? This is where Mitolyn stands out from other weight loss supplements. This formula works on a recent scientific study by Harvard scientists. A group of Harvard scientists has found that mitochondria are directly linked to body weight.
As part of a research study, conducted on 1,700 men and women, these scientists found that overweight people have a common factor: low mitochondrial levels. So, if the mitochondrial levels increase, body weight can be reduced. But how is that possible? That's because, with more mitochondria, more ATP will be produced. This helps burn more calories naturally. So, the ingredients in Mitolyn help achieve this goal. They boost mitochondrial functions, which leads to improved metabolism and significant weight loss. So, Mitolyn is a safe metabolism booster for weight loss.
>>Meet the New Fat Burner Everyone's Talking About — No Stimulants Needed!
Inside Mitolyn: The Ingredients That Make It Work
Ingredients have a major role in the efficiency of the Mitolyn supplement. Based on my analysis, Mitolyn has a proprietary blend of six natural and tested ingredients. Let's see the details:
Maqui Beryy
A popular purple berry, Maqui Berry, is rich in antioxidants, anthocyanins, and other nutrients. These elements are proven to help with weight loss by improving mitochondrial levels in the users. So, they make MNitolyn an antioxidant-rich weight loss supplement.
Rhodiola
Rhodiola has been a part of various medicinal components for centuries. It has almost 140 polyphenols, such as rosavin and salidroside, that help elevate metabolic activities. So, as metabolism increases, it positively affects weight management.
Amla
Amla is a special fruit that has been proven to have various medicinal properties. As per studies, the flavonoids, antioxidants, and essential nutrients in this fruit help promote mitochondrial levels, improve digestion, and enhance vision.
Schisandra
Schisandra is a red berry rich in antioxidants. The antioxidants in this berry benefit metabolism by preventing free radical buildup and oxidative stress. This results in reducing body weight.
Theobroma Cacao
Studies have proved that Theobroma Cacao can be a good and effective component in weight loss diets. The high amounts of fiber, protein, and healthy fat in this ingredient create a feeling of fullness in people, curbing cravings and appetite.
>> Want to Transform Your Body the Natural Way? Learn About Mitolyn's Plant-Based Ingredients Here!
How to Take Mitolyn for Best Results
No matter how good a supplement is, following its usage and dosage instructions is mandatory to gain optimal results. The capsule design of this formula attracted me at first glance. While consuming some other supplements involves various steps, and takes more time, this capsule form makes taking Mitolyn simple and easy. Looking into the dosage, according to the official information, the ideal dosage of Mitolyn is one capsule a day. Taking this pill with a big glass of cold water will help improve absorption. Moreover, stay consistent and use the supplement daily for better results.
Additionally, stay within the dosage limits. Moreover, people with an underlying medical condition should consult a medical professional before using Mitolyn. Although no cases of medication interactions have been reported, pregnant and nursing women are asked not to take the supplement.
How This Supplement Can Help You Feel Your Best
As said in the previous section, Mitolyn is not merely a weight loss support formula. The certified ingredients in this supplement also offer various other health benefits, including:
Promotes mitochondrial growth
As you have already seen, Mitolyn works by focusing on the enhancement of mitochondria in overweight people. So, most ingredients in this formula, including Maqui Berry, Rhodiola, and others, help increase the number of mitochondria.
Increases natural weight loss
The ultimate aim of Mitolyn is to help users gain faster weight loss. So, the ingredients in this formula aid fat oxidation, appetite control, and curb cravings to increase natural weight loss.
Other benefits
Supports heart and brain health
Maintains healthy blood pressure and cholesterol levels
Improves digestive functions
Are There Any Side Effects with Mitolyn? Here's What I Found
Are you afraid of trying a new dietary supplement due to the potential side effects you might encounter? I also had similar fears and reluctance before trying Mitolyn. However, I conducted thorough research about the potential side effects of the supplement, and much to my surprise, most customer reviews were largely positive. I did not find details of any major side effects. My first-hand experience is also the same. I did not experience any side effects even in the initial days of using Mitolyn. Everything went so well for me. The major reason behind this is the safe and science-backed ingredients and FDA and GMP-certified lab facilities. Moreover, the multiple third-party safety tests also make Mitolyn free of side effects.
Hear from People Who Tried Mitolyn...
Do you cross-check customer reviews before purchasing a supplement? I always do that. The same was done before buying Mitolyn as well. However, unlike most other supplements, the customer reviews were significantly positive all over the internet. The official website, as well as other internet platforms, offered customer reviews that praised the efficiency and effectiveness of Mitolyn. While the majority of customers praised the supplement for offering visible results within a couple of months, some, like me, were happy as we did not face any side effects, even in the initial use.
The additional benefits offered by Mitolyn, including blood pressure and cholesterol control, immune response enhancement, increased mitochondrial production, improved vision, and more, also attracted customers. So, based on these reviews, it is clear that Mitolyn is a safe and efficient weight loss formula that helps attain the desired weight with no side effects or reactions.
Real Experiences Shared by Users
Through this Mitolyn review, you have been analyzing my experience with this supplement for mitochondrial support. So, in this section, let's see what other customers have to share about Mitolyn.
Jacob, South Carolina
I was always conscious of my weight, which reduced my confidence significantly. However, after using Mitolyn, I could experience changes in my body, which helped me believe in myself. This supplement helped me lose weight and regain my confidence.
Caroline, New Jersey
I have tried various weight loss supplements. Even after typing so hard, I could not reach my weight loss goal. My belly fat was so stubborn that even after trying various supplements, diet plans, and workouts, it remained intact. However, this problem remained only till I used Mitolyn. This supplement worked well for me.
Josephine, Los Angeles
Mitolyn has helped me increase my energy levels and lose several pounds. Would you believe if I told you that I lost over 25 pounds in just a couple of months? Yes, Mitolyn helped me achieve it.
What Some Customers Didn't Love
While searching for an ideal weight management formula, I came across numerous popular supplements. However, even though these supplements had positive feedback, I found various customer complaints regarding their effectiveness and results, which prevented me from trying them. But, to my surprise, I did not find any major complaints regarding the Mitolyn supplement.
Almost all reviews were satisfactory. This was the major reason I decided to try this formula. My experience with Mitolyn was also similar. I did not face any side effects, allergies, or other issues. The formula was effective for me with efficient ingredients and a working mechanism. However, there might be chances of delays in deliveries due to limited availability.
>>Want to feel the difference? Grab your bottle of Mitolyn now!
The Benefits and Drawbacks You Should Know
I was so conscious about the potential drawbacks Mitolyn might possess. So, I conducted thorough research and found that the benefits of the supplement are more compared to the drawbacks. Let's see what these benefits and drawbacks are:
Pros
Formulated with tested, all-natural ingredients
All the lab facilities used for manufacturing are approved by the FDA and certified by GMP
Mitolyn is a GMO-free formula with no side effects
Ensure safe shopping with a 90-day money-back guarantee
Offers two free bonuses with every bundle order
With a capsule design, Mitolyn offers ease of use
Cons
Difficulty in purchasing due to limited availability
Results may vary depending on the users
Does Mitolyn Deal With Fake Reviews?
Mitolyn's official website makes it clear: they recommend buying directly from their site. That way, you can avoid fake reviews and knock-off products sold by shady third parties. When you order through the official site, you're guaranteed a genuine product, full access to customer support, and any money-back promises they offer.
Still, it's smart to stay realistic. Like with any weight loss pill, results can vary from person to person. Some of the 'scam' complaints you'll see out there usually come from people misunderstanding how supplements work — or feeling let down when the results didn't live up to the big claims they read online.
Where to Order the Supplement Safely
Some of you might be confused about how to purchase Mitolyn. I was in the same situation once. I came across various supplements that claimed to be the authentic Mitolyn on popular e-commerce websites like Amazon, Walmart, and eBay. At first, I thought of buying this supplement for mitochondrial health from those websites as they seemed to offer more discounts. However, then, I realized that the authentic Mitolyn is available only on its official website. All other supplements I found on other websites were mere copycats, which might even cause serious side effects. So, if you plan to try this formula, ensure that you purchase it from its official website.
Supplement Pricing and Packages
Natural dietary supplements might be a little expensive, aren't they? Previously, I could not try a weight loss supplement as it was unaffordable for me. However, Mitolyn seems different. Unlike some other natural formulas, Mitolyn is available at affordable prices that can be easily accessed even by common people. Moreover, the official website offers multiple packages, including single and bundle orders with noteworthy discounts and other offers. Although left to the convenience of the buyers, I would suggest buying bundle orders as they are more affordable and offer value for money. More than discounts, these bundles also offer two free bonuses and free US shipping for the most popular package of 6 bottles. Below are the details of each package of Mitolyn:
1 bottle: 30-day supply: $79 per bottle
3 bottles: 90-day supply: $177 + 2 free bonuses
6 bottles: 180-day supply: $294 + 2 free bonuses and free US shipping
The Mitolyn's offers do not end with this. All orders are also secured with its iron-clad 90-day money-back guarantee. So, if any of you find Mitolyn ineffective for you, you can return it within 90 days and earn a 100% refund. Doesn't that seem interesting?
Free Bonuses Included
As mentioned in the previous section, the bundle orders of Mitolyn offer two free bonuses. These bonuses have helped me enhance the overall results of the supplement. Let's have a glance at the details of each of these bonuses.
Bonus #1: 1-Day Kickstart Detox
This is an e-guide that offers recipes for 20 detox drinks that can be made using everyday ingredients. These teas help detox, cleanse, and purify the organs, improving absorption.
Bonus #2: Renew You
This e-guide helps calm your mind by reducing stress. This book consists of simple methods that can offer instant stress relief by reducing anxiety and boosting confidence.
How Mitolyn Supports Better Lifestyle Habits
While Mitolyn is designed to help with fat burning, it works best when it's part of a healthy lifestyle. According to 2025 reviews, people who saw the best results didn't rely on the supplement alone — they made smart daily choices too.
Here's what they typically did:
Stayed active throughout the day, even with simple movement.
Made healthy, balanced meals a priority.
Stuck to a regular sleep schedule.
Added Mitolyn into their overall wellness routine, not as a quick fix.
Blending Mitolyn into a healthy lifestyle not only boosted their weight loss efforts but also made it easier to avoid common setbacks and stay on track for the long haul.
>>Stay active throughout the day, even with simple movements like walking or stretching.
Planning Ahead with Mitolyn
If you're thinking long-term, Mitolyn makes it easy — it's usually sold in 3, 6, or even 12-month bundles. A lot of people who had great results said it wasn't just about taking the supplement once or twice; it was about staying consistent over a few months. That steady routine helped them build better habits and see real, lasting changes.
One quick tip: be sure to check the official Mitolyn website for the latest deals, package options, and guarantee details. Things like pricing and offers can shift without much warning.
Here's the Bottom Line of Mitolyn Reviews
I have concluded my review of Mitolyn. So, after going through my experience, what do you feel? Is Mitolyn ideal for you? If you ask me, I would suggest that Mitolyn is a good metabolism booster that will help you lose weight naturally. The science-backed ingredients, certified manufacturing facilities, and third-party safety tests ensure that the safety of the supplement is well-maintained. Moreover, they also confirm that the supplement is BPA and GMO-free, eliminating the chances of side effects. Apart from my experience, we have discussed the comments of other users, which confirm that Mitolyn is safe.
Moreover, you have seen the affordable prices, discounts, and other bonuses offered by this formula. More than that, it also provides risk-free shopping with a 90-day money-back guarantee. So, with noteworthy features in working, development, and customer satisfaction, Mitolyn is a weight loss aid that I would recommend to anyone trying to lose weight.
Common Questions About the Mitolyn Supplement
Who can take Mitolyn capsules?Being a natural and safe formula, Mitolyn can be taken by all adults regardless of age and gender.
Can Mitolyn be used to treat an existing medical condition?No. Mitolyn is a dietary supplement and cannot be used to treat any underlying medical condition.
Can I connect with the customer support team Mitolyn?Yes. You can reach out to the Mitolyn customer team in the following ways:
Product email support:
Order phone support: 1-800-390-6035 (US), +1-208-345-4245 (International)
What is the best way to take Mitolyn pills?Taking one Mitolyn capsule with a big glass of cold water is the best way to gain maximum results.
Does Mitolyn offer a subscription policy?No. All payments of Mitolyn are one-time and do not include any subscription offers.
Email: contact@Mitolyn.com
Disclaimer: The details provided about Mitolyn have not been evaluated by the Food and Drug Administration. This supplement is not intended to diagnose, treat, cure, or prevent any medical condition. Results may vary from person to person. As with any dietary supplement, it's essential to consult your healthcare provider before beginning use—particularly if you are on medication or have an existing health concern.
This article is for informational and educational purposes only and is not a substitute for professional medical advice. Some of the links included may be affiliate links, which means we may earn a small commission if you choose to make a purchase through them. Always speak with a qualified medical professional before incorporating Mitolyn—or any supplement targeting mitochondrial or metabolic health—into your daily routine.
Photos accompanying this announcement are available at :
https://www.globenewswire.com/NewsRoom/AttachmentNg/813911a7-88dc-496a-88e9-b8832b8552f9
https://www.globenewswire.com/NewsRoom/AttachmentNg/e99b18b2-d8ba-42ac-a01e-c285a09599f8

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition trial met its primary endpoint showing statistically significant and clinically meaningful benefit for Pluvicto™ plus hormone therapy versus hormone therapy alone, with positive trend in overall survival (OS)1 Pluvicto is already approved for metastatic castration-resistant prostate cancer (mCRPC) and now shows potential in patients in an earlier disease setting1,2 Novartis to present results at an upcoming medical meeting and, based on FDA feedback, will submit for regulatory review in the second half of the year Novartis is investigating a broad portfolio of RLTs in advanced cancers, including breast, colon, lung and pancreatic and is investing in multiple manufacturing facilities, with industry-leading infrastructure to accelerate delivery of RLTs to patients Basel, June 2, 2025 – Novartis today announced topline results from a pre-specified interim analysis of the Phase III PSMAddition trial. The trial met its primary endpoint with a statistically significant and clinically meaningful benefit in radiographic progression-free survival (rPFS) with a positive trend in overall survival (OS) in patients with prostate-specific membrane antigen (PSMA)-positive metastatic hormone-sensitive prostate cancer (mHSPC) treated with radioligand therapy (RLT), Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan), in combination with standard of care (SoC) versus SoC alone1. In PSMAddition, the SoC is a combination of androgen receptor pathway inhibitor (ARPI) therapy and androgen deprivation therapy (ADT)3. Almost all mHSPC patients ultimately progress to metastatic castration-resistant prostate cancer (mCRPC)4. There is a need for additional treatment options with novel mechanisms of action that further delay progression, prolong OS and improve disease control compared to the current SoC, while showing a favorable safety and tolerability profile. 'The progression from metastatic hormone-sensitive prostate cancer to castration-resistant disease remains a formidable challenge that can profoundly impact the survival of patients," said Shreeram Aradhye, M.D., President, Development and Chief Medical Officer at Novartis. "These results further strengthen our confidence in Pluvicto as a PSMA-targeted radioligand therapy. Following the recent FDA approval based on the PSMAfore trial in metastatic castration-resistant prostate cancer, these data suggest using it in an earlier disease setting could advance care and address a significant unmet need for hormone-sensitive prostate cancer patients." This is the third positive read-out for Pluvicto in a Phase III trial, following the VISION and PSMAfore studies5,6. Results from PSMAddition in mHSPC show potential for treatment in an earlier setting with Pluvicto, which was recently granted US Food and Drug Administration (FDA) approval for earlier use in mCRPC, based on results from PSMAfore1,2. Novartis is harnessing the innovation of world-class scientists, strategic partnerships and one of the industry's most competitive pipelines to explore the potential of new, targeted therapies and precision medicine platforms to address the greatest unmet needs in prostate cancer. Data will be presented at an upcoming medical meeting and, based on FDA feedback, will be submitted for regulatory review in the second half of the year. About PSMAddition studyPSMAddition (NCT04720157) is a Phase III, open-label, prospective, 1:1 randomized study comparing the efficacy and safety of Pluvicto in combination with SoC (ARPI + ADT) vs. SoC alone in adult patients with PSMA-positive mHSPC3. Patients randomized to the SoC alone arm are allowed to crossover to receive Pluvicto, upon confirmation of radiographic progression by blinded independent review committee (BIRC) and per the discretion of the treating physician3. The primary endpoint is rPFS, defined as the time to radiographic progression by PCWG3-modified RECIST V1.1 (as assessed by BIRC) or death3. The key secondary endpoint of OS is defined as time to death due to any cause3. About Pluvicto™ (INN: lutetium (177Lu) vipivotide tetraxetan)Pluvicto is an intravenous RLT that combines a targeting compound (a ligand) with a therapeutic radionuclide (a radioactive particle, in this case lutetium-177)5,7. After administration into the bloodstream, Pluvicto binds to PSMA-expressing target cells, including prostate cancer cells that express PSMA, a transmembrane protein5,7. Once bound, energy emissions from the radioisotope damage the target cells and nearby cells, disrupting their ability to replicate and/or triggering cell death7. Pluvicto is the only PSMA-targeted agent approved for PSMA-positive mCRPC and is the first targeted RLT to demonstrate a clinical benefit for patients with PSMA-positive mHSPC1. Novartis is investigating Pluvicto in earlier stages of disease, including oligometastatic prostate cancer (PSMA-DC, NCT05939414). Novartis and radioligand therapy (RLT)Novartis is reimagining cancer care with RLT for patients with advanced cancers. By harnessing the power of targeted radiation and applying it to advanced cancers, RLT is designed to deliver treatment directly to target cells, anywhere in the body8,9. Novartis is investigating a broad portfolio of RLTs, exploring new isotopes, ligands and combination therapies to look beyond gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and prostate cancer and into breast, colon, lung and pancreatic cancer. Novartis has established global expertise, with specialized supply chain and manufacturing capabilities across its network of RLT production sites. To support growing demand for RLTs, we have expanded production capabilities in Millburn (NJ), Zaragoza (Spain), Ivrea (Italy) and a state-of-the-art facility in Indianapolis (IN). In Carlsbad (CA), Novartis is establishing its third US-based RLT manufacturing site to support expanded use of RLTs, create resiliency in its manufacturing network and optimize the delivery of medicines to patients on the West Coast. DisclaimerThis press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as 'potential,' 'can,' 'will,' 'may,' 'could,' 'trend,' 'potentially,' 'upcoming,' 'progression,' 'progress,' 'investigating,' 'investing,' 'look beyond,' or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for Pluvicto, or regarding potential future revenues from Pluvicto. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that Pluvicto will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that Pluvicto will be commercially successful in the future. In particular, our expectations regarding Pluvicto could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. About Novartis Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people's lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide. Reimagine medicine with us: Visit us at and connect with us on LinkedIn, Facebook, X/Twitter and Instagram. References Data on file. Pluvicto [prescribing information]. Millburn, NJ: Advanced Accelerator Applications USA, Inc.; 2025. An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC (PSMAddition). identifier: NCT04720157. Updated March 5, 2025. Accessed June 2, 2025. Oing C, Bristow RG. Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy. ESMO Open 2023l doi: 10.1016/ Sartor O, J. de Bono KN, Chi K, et al. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer. NEJM 2021; doi: 10.1056/NEJMoa2107322. Morris M, Castellano D, Herrmann K, et al. 177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial. The Lancet 2024; doi: 10.1016/S0140-6736(24)01653-2. University of Chicago Medicine. Lutetium-177 PSMA Therapy for Prostate Cancer (Pluvicto). Accessed June 18, 2024. Jadvar H. Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment [published correction appears in AJR Am J Roentgenol. 2017 Oct;209(4):949. doi: 10.2214/AJR.17.18875]. AJR Am J Roentgenol. 2017;209(2):277-288. doi:10.2214/AJR.17.18264 Jurcic JG, Wong JYC, Knoc SJ, et al. Targeted radionuclide therapy. In: Tepper JE, Foote RE, Michalski JM, eds. Gunderson & Tepper's Clinical Radiation Oncology. 5th ed. Elsevier, Inc. 2021;71(3):209-249 # # # Novartis Media RelationsE-mail: Novartis Investor RelationsCentral investor relations line: +41 61 324 7944E-mail: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Man seriously injured after SUV collides with semi-truck near Harvard
HARVARD, Ill. — A two-vehicle crash involving an SUV and a semi-truck in Harvard sent one man to the hospital with serious injuries Sunday afternoon. The Harvard Fire Protection District was dispatched to the area of Route 173 and Crowley Road for a reported crash with entrapment just after 2:30 p.m. While crews were en route, multiple 911 callers reported that an SUV had collided with a semi-truck and that the adult male driver of the SUV was trapped inside. Officials say one of the vehicles had left the roadway and came to rest in a wooded area. Firefighters freed the driver of the SUV from the vehicle in under 10 minutes. The driver of the SUV was airlifted to Javon Bea Hospital-Riverside in Rockford with serious injuries. The female driver of the semi-truck was not injured. Route 173 remained closed in both directions for about two hours as emergency crews worked on the scene. The McHenry County Sheriff's Office is investigating the events leading up to the crash. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


Business Insider
3 hours ago
- Business Insider
Teva announces results from a study of treatment patterns of tardive dyskinesia
Teva (TEVA) Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries, announced results from a study of treatment patterns among patients with tardive dyskinesia residing in long-term care facilities, highlighting a critical gap in TD diagnosis and treatment. Key results from the study revealed: Of the residents being treated with antipsychotic drugs, 5.6% had a diagnosis of extrapyramidal syndrome, – a broad term used to describe any drug-induced movement disorder with no wide-treating therapeutic option – while 1.1% had a specific diagnosis of TD. The most common comorbidities observed in residents on APDs at risk for TD included dementia, chronic pulmonary disease and congestive heart failure. Moderate or severe liver disease was observed in less than1% of residents on APDs. Less than half of patients diagnosed with TD residing in LTC settings received the standard of care treatment recommended by the American Psychiatric Association – a vesicular monoamine transporter 2 inhibitor. The majority were treated with a non-FDA approved treatment, primarily benztropine, and a quarter were not treated at all. Confident Investing Starts Here: